Bck Capital Management LP Cytokinetics Inc Call Options Transaction History

Bck Capital Management LP

  • $289 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$51.22 - $60.16 $1.02 Million - $1.2 Million
-20,000 Reduced 20.47%
77,700 $4.1 Million
Q2 2024

Aug 07, 2024
BUY
$47.86 - $75.05 $23,930 - $37,525
500 Added 0.51%
97,700 $5.29 Million
Q1 2024

May 08, 2024
BUY
$63.75 - $108.06 $6.2 Million - $10.5 Million
97,200 New
97,200 $6.81 Million

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.85B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Bck Capital Management LP Portfolio

Follow Bck Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bck Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Bck Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email